Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy

Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy

US Patent 6544504 · Granted Apr 8, 2003

Estimated economic value: $119,083,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfonyl-substituted bicyclic compounds as PPAR modulators for the treatment of 2016
IL-12P40 and IL-B30 polypeptide complex2011
Mammalian genes; related reagents and methods2007
Mammalian cytokines; related reagents and methods2006
Treatment of hepatitis C virus infections with interleukin-102004
Combination therapy for chronic hepatitis C infection2002
Combination therapy for chronic hepatitis c infection2001
Materials and methods for screening human interleukin-4 antagonists/agonists2001
Method for treating or preventing ischemia-reperfusion injury2000
Human gamma interferon antagonist/agonist screen1999
Human interleukin-4 antagonist/agonist screens1999
Method for treating inflammation1998